On the surface, YTC have so much promise, but has hit a barrier of sorts. Could the selloff be related to financing not likely to come through?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025